Karen L. Daniel - 17 Nov 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
17 Nov 2023
Net transactions value
$0
Form type
4
Filing time
20 Nov 2023, 16:06:02 UTC
Previous filing
02 Nov 2023
Next filing
21 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +436 +0.86% 51,068 17 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -436 -100% $0.000000* 0 17 Nov 2023 Common Stock 436 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 The restricted stock units vest in three substantially equal annual installments beginning November 19, 2021.